Human health risk assessment of the mixture of pharmaceuticals in Dutch drinking water and its sources based on frequent monitoring data

Science of the Total Environment

Volumn 496, Issue , 2014, Pages 54-62

  Houtman, Corine J ^a   Kroesbergen, Jan ^a   Lekkerkerker Teunissen, Karin ^b   van der Hoek, Jan Peter ^c,d  

^a Water Laboratory   (Netherlands)

^b Dunea Dune and Water   (Netherlands)

^c DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^d Waternet   (Netherlands)

Author keywords

Drinking water; Exposure assessment; Mixture toxicity; Pharmaceuticals; Threshold of toxicological concern

Indexed keywords

DRUG PRODUCTS; HEALTH; HEALTH RISKS; LARGE DATASET; MIXTURES; MONITORING; POTABLE WATER; RISK PERCEPTION; TOXICITY;

ADVERSE HEALTH EFFECTS; AVERAGE CONCENTRATION; CONCENTRATION ADDITION; DRINKING WATER PRODUCTION; EXPOSURE ASSESSMENT; HUMAN HEALTH RISK ASSESSMENT; MIXTURE TOXICITY; THRESHOLD OF TOXICOLOGICAL CONCERN;

RISK ASSESSMENT;

DRINKING WATER; DRUG; SURFACE WATER; WATER POLLUTANT;

ADVERSE OUTCOME; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HEALTH HAZARD; HUMAN; NETHERLANDS; REFERENCE VALUE; RISK ASSESSMENT; WATER ANALYSIS; WATER CONTAMINATION; WATER MANAGEMENT; WATER QUALITY; WATER SAMPLING; WATER STANDARD; WATER SUPPLY; ANALYSIS; CHEMISTRY; STATISTICS AND NUMERICAL DATA; WATER POLLUTANT;

DRINKING WATER; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HUMANS; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

EID: 84904741475     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2014.07.022     Document Type: Article

References (47)

1. Backhaus T., Faust M. Predictive environmental risk assessment of chemical mixtures: a conceptual framework. Environ Sci Technol 2012, 46:2564-2573.
2. Bannink A. Jaarraport 2011 Maas 2012, 1-56. Association of River waterworks Meuse, Maastricht, the Netherlands.
3. Bauerlein P., Hofman J., Ter Laak Th. Vo´o´rkomen en voorko´men van geneesmiddelen in bronnen van drinkwater. BTO.2013.049 2013, 1-25. KWR Watercycle Research Institute, Nieuwegein, The Netherlands.
4. Benotti M.J., Stanford B.D., Wert E.C., Snyder S.A. Evaluation of a photocatalytic reactor membrane pilot system for the removal of pharmaceuticals and endocrine disrupting compounds from water. Water Res 2009, 43:1513-1522.
5. Benotti M.J., Trenholm R.A., Vanderford B.J., Holady J.C., Stanford B.D., Snyder S.A. Pharmaceuticals and endocrine disrupting compounds in US drinking water. Environ Sci Technol 2009, 43:597-603.
6. Boobis A., Budinsky R., Collie S., Crofton K., Embry M., Felter S., et al. Critical analysis of literature on low-dose synergy for use in screening chemical mixtures for risk assessment. Crit Rev Toxicol 2011, 41:369-383.
7. Boxall A.B., Rudd M.A., Brooks B.W., Caldwell D.J., Choi K., Hickmann S., et al. Pharmaceuticals and personal care products in the environment: what are the big questions?. Environ Health Perspect 2012, 120:1221.
8. Bruce G.M., Pleus R.C., Snyder S.A. Toxicological relevance of pharmaceuticals in drinking water. Environ Sci Technol 2010, 44:5619-5626.
9. Cleuvers M. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol Environ Saf 2004, 59:309-315.
10. Cunningham V.L., Binks S.P., Olson M.J. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment. Regul Toxicol Pharmacol 2009, 53:39-45.
11. Cunningham V.L., Perino C., D'Aco V.J., Hartmann A., Bechter R. Human health risk assessment of carbamazepine in surface waters of North America and Europe. Regul Toxicol Pharmacol 2010, 56:343-351.
12. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Perspect 1999, 107(Suppl. 6):907-938.
13. de Jongh C.M., Kooij P.J.F., de Voogt P., ter Laak T.L. Screening and human health risk assessment of pharmaceuticals and their transformation products in Dutch surface waters and drinking water. Sci Total Environ 2012, 427-428:70-77.
14. De Moel P.J., Verberk J.Q.J.C., Van Dijk J.C. Drinkwater - principes en praktijk 2004, Delft Technical University/SDU Publishers B.V., The Hague.
15. Du B., Price A.E., Scott W.C., Kristofco L.A., Ramirez A.J., Chambliss C.K., et al. Comparison of contaminants of emerging concern removal, discharge, and water quality hazards among centralized and on-site wastewater treatment system effluents receiving common wastewater influent. Sci Total Environ 2014, 466:976-984.
16. Godfrey E., Woessner W.W., Benotti M.J. Pharmaceuticals in on-site sewage effluent and ground water, Western Montana. Ground Water 2007, 45:263-271.
17. Halling-Sorensen B., Nielsen S.N., Lanzky P.F., Ingerslev F., Lutzhoft H.C.H., Jorgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 1998, 36:357-394.
18. Health Council of the Netherlands Ifosfamide. Evaluation of the carcinogenicity and genotoxicity. 2008/06OSH 2008, Health Council of the Netherlands, The Hague, The Netherlands.
19. Houtman C.J. Emerging contaminants in surface waters and their relevance for the production of drinking water in Europe. J Integr Environ Sci 2010, 7:271-295.
20. Houtman C.J., ten Broek R., de Jong K., Pieterse B., Kroesbergen J. A multi-component 'snapshot' of pharmaceuticals and pesticides in the river Meuse basin. Environ Toxicol Chem 2013, 32:2449-2459.
21. Houtman C.J., Van Houten Y.K., Leonards P.E., Brouwer A., Lamoree M.H., Legler J. Biological validation of a sample preparation method for ER-CALUX bioanalysis of estrogenic activity in sediment using mixtures of xeno-estrogens. Environ Sci Technol 2006, 40:2455-2461.
22. Hut R., Van de Giesen N., Houtman C.J. Medicinal Footprint of the population of the Rhine basin. Environ Res Lett 2013, 8. [044057-, 7pp.].
23. International Agency for Research on Cancer IARC monographs on the evaluation of the cancer risk of chemicals to humans. Some antineoplastic and immunosuppressive agents 1981, vol. 26:1-396. IARC, Lyon France, [Geneva, Switzerland, World Health Organization Press].
24. International Agency for Research on Cancer IARC monographs. Pharmaceuticals. A review of human carcinogens 2012, vol. 100A:1-462. IARC, Lyon France, [Geneva, Switzerland, World Health Organization Press].
25. Johnson A.C., Juergens M.D., Williams R.J., Kuemmerer K., Kortenkamp A., Sumpter J.P. Do cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment and human health? An overview and UK case study. J Hydrol 2008, 348:167-175.
26. Jones O.A., Lester J.N., Voulvoulis N. Pharmaceuticals: a threat to drinking water?. Trends Biotechnol 2005, 23:163-167.
27. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. Multiresidue methods for the analysis of pharmaceuticals, personal care products and illicit drugs in surface water and wastewater by solid-phase extraction and ultra performance liquid chromatography-electrospray tandem mass spectrometry. Anal Bioanal Chem 2008, 391:1293-1308.
28. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ Sci Technol 2002, 36:1202-1211.
29. Lekkerkerker-Teunissen K., Chekol E.T., Maeng S.K., Ghebremichael K., Houtman C.J., Verliefde A.R.D., et al. Pharmaceutical removal during managed aquifer recharge with pretreatment by advanced oxidation. Water Sci Technol Water Supply 2012, 12:755-767.
30. Mons M.N., Heringa M.B., van Genderen J., Puijker L.M., Brand W., van Leeuwen C.J., et al. Use of the Threshold of Toxicological Concern (TTC) approach for deriving target values for drinking water contaminants. Water Res 2012, 47:1666-1678.
31. Payne J., Rajapakse N., Wilkins M., Kortenkamp A. Prediction and assessment of the effects of mixtures of four xenoestrogens. Environ Health Perspect 2000, 108:983-987.
32. Richardson S.D., Ternes T.A. Water analysis: emerging contaminants and current issues. Anal Chem 2011, 83:4614-4648.
33. Scheurer M., Sacher F., Brauch H.J. Occurrence of the antidiabetic drug metformin in sewage and surface waters in Germany. J Environ Monit 2009, 11:1608-1613.
34. Scheurer M., Storck F.R., Brauch H.J., Lange F.T. Performance of conventional multi-barrier drinking water treatment plants for the removal of four artificial sweeteners. Water Res 2010, 44:3573-3584.
35. Schriks M., Heringa M.B., van der Kooi M.M., de V.P., van Wezel A.P. Toxicological relevance of emerging contaminants for drinking water quality. Water Res 2009, 44:461-476.
36. Snyder S.A., Trenholm R.A., Snyder E.M., Bruce G.M., Pleus R.C., Hemming J.D.C. Toxicological relevance of EDCs and pharmaceuticals in drinking water 2008, Awwa Research Foundation, Denver, California, U.S.A.
37. Spencer Williams E., Brooks B.W. Human health risk assessment for pharmaceuticals in the environment: existing practice, uncertainty, and future directions. Current and future perspectives 2012, 167-224. Springer, New York. B.W. Brooks, D.B. Huggett (Eds.).
38. Stanford B.D., Weinberg H.S. Evaluation of on-site wastewater treatment technology to remove estrogens, nonylphenols, and estrogenic activity from wastewater. Environ Sci Technol 2010, 44:2994-3001.
39. Ter Laak T.L., van der Aa M., Houtman C.J., Stoks P.G., van Wezel A.P. Relating environmental concentrations of pharmaceuticals to consumption: a mass balance approach for the river Rhine. Environ Int 2010, 36:403-409.
40. Van der Aa N.G.F.M., Kommer G.J., Van Montfoort J.E., Versteegh J.F.M. Demographic projections of future pharmaceutical consumption in the Netherlands. Water Sci Technol 2011, 63:825-831.
41. Versteegh J.F.M., Van der Aa N.G.F.M., Dijkman E. Geneesmiddelen in drinkwater en drinkwaterbronnen. RIVM Report 703719016/2007 2007, 1-53. Dutch Ministry for Public Health and the Environment, Bilthoven.
42. Villanueva C.M., Kogevinas M., Cordier S., Templeton M.R., Vermeulen R., Nuckols J.R., et al. Assessing exposure and health consequences of chemicals in drinking water: current state of knowledge and research needs. Environ Health Perspect 2014, 122(3):213-221.
43. Vulliet E., Cren-Olive´ C. Screening of pharmaceuticals and hormones at the regional scale, in surface and groundwaters intended to human consumption. Environ Pollut 2011, 159:2929-2934.
44. Walpole S., Prieto-Merino D., Edwards P., Cleland J., Stevens G., Roberts I. The weight of nations: an estimation of adult human biomass. BMC Public Health 2012, 12:439.
45. Webb S., Ternes T., Gibert M., Olejniczak K. Indirect human exposure to pharmaceuticals via drinking water. Toxicol Lett 2003, 142:157-167.
46. World Health Organization Guidelines for drinking-water quality. incorporating first and second addenda 2006, vol. 1. World Health Organization, Geneva, Switzerland. third ed.
47. World Health Organization Pharmaceuticals in drinking water 2012, World Health Organization, Geneva, Switzerland.